The first patient has been dosed in a phase 1 clinical trial of CT-95 among patients with mesothelin-expressing solid tumors.

Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients ...

The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.

The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.

Cancer is a distraction and not always a bad one. We do learn perspective. There are some good things we can take away in ...

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and ...